United States

Underlining the UK's rich heritage in developing drugs, Scottish company ProStrakan's granisetron transdermal patch, Sancuso, has been approved by the US FDA for the prevention of... 2008-09-16

A study in the American Journal of Managed Care has attempted to put an economic value on surgical intervention in the treatment of obesity in the US. The paper finds that the initial... 2008-09-12

A paper published in open access science journal PLoS ONE has shown that physicians in the US mostly resort to off-label drugs to treat schizophrenia patients. Over half of patients... 2008-09-11

US-based healthcare company Johnson & Johnson (J&J) has closed its Australian biotechnology research facility to 'rationalise' its global R&D efforts. The hi-tech operation... 2008-09-05

Biotechnology firm Cytos is to link up with US pharmaceutical giant Pfizer in the development of vaccines for a number of human diseases, the Swiss firm announced on August 15 2008.... 2008-08-21

Prestwick Pharmaceuticals has received US FDA orphan drug approval for Xenazine (tetrabenazine). Xenazine will be the first drug available in the US for the treatment of Huntington's... 2008-08-18

Sales from outside Western Europe continued to drive French firm Ipsen's growth in H108. Underlying sales -calculated at a constant exchange rate and excluding sales for Ginkor Fort... 2008-08-13

As a strategy, outsourcing forms a key part of US-based Eli Lilly's drive to streamline its R&D processes. Over the past few years, the company, like many multinational drugmakers,... 2008-08-08

Gilead Sciences' Viread (tenofovir) and Truvada (emtricitabine) will be tested in single and combination doses in about 16,000 uninfected healthy people for pre-exposure prophylaxis... 2008-08-07

The US FDA has released its list of approved seasonal influenza vaccines for the 2008-2009 season. A total of six vaccines have been approved, which protect against new strains of... 2008-08-07